| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 237,8 k € | +21.1% | 196,4 k € | +29.4% | 151,8 k € | +46.3% | 103,7 k € | -13.6% | 120,1 k € | +21.6% | 98,7 k € | +24.8% | 79,1 k € | +80.0% | 43,9 k € | +9.4% | 40,2 k € | -35.2% | 62,0 k € | +56.6% | 39,6 k € | +69.1% | 23,4 k € | -8.1% | 25,5 k € | +24.3% | 20,5 k € | -13.7% | 23,8 k € | +42.6% | 16,7 k € | +40.2% | 11,9 k € | +114.7% | 5,5 k € | -35.7% | 8,6 k € | |
| EBITDA | 236,1 k € | +21.3% | 194,7 k € | +29.6% | 150,3 k € | +47.3% | 102,0 k € | -13.6% | 118,1 k € | +21.4% | 97,2 k € | +24.9% | 77,9 k € | +77.2% | 43,9 k € | +13.1% | 38,9 k € | -35.4% | 60,2 k € | +59.4% | 37,8 k € | +76.0% | 21,5 k € | -8.1% | 23,3 k € | +25.7% | 18,6 k € | -14.6% | 21,7 k € | +49.2% | 14,6 k € | +42.6% | 10,2 k € | +168.8% | 3,8 k € | -47.6% | 7,3 k € | |
| Operating profit | 195,1 k € | +17.0% | 166,7 k € | +37.7% | 121,1 k € | +52.9% | 79,2 k € | -17.4% | 95,8 k € | +12.2% | 85,4 k € | +42.3% | 60,0 k € | +36.6% | 43,9 k € | +102.2% | 21,7 k € | -52.7% | 45,9 k € | +125.8% | 20,3 k € | +190.8% | 7,0 k € | +91.0% | 3,7 k € | +128.0% | 1,6 k € | -77.7% | 7,2 k € | +45.8% | 4,9 k € | +29.3% | 3,8 k € | +2573.6% | 142,9 € | -95.8% | 3,4 k € | |
| Profit/loss | 137,6 k € | +14.1% | 120,6 k € | +39.4% | 86,5 k € | +55.6% | 55,6 k € | -19.3% | 68,8 k € | +9.5% | 62,9 k € | +53.2% | 41,0 k € | +39.0% | 29,5 k € | +140.3% | 12,3 k € | -56.8% | 28,4 k € | +103.8% | 14,0 k € | +260.1% | 3,9 k € | +73.4% | 2,2 k € | +321.4% | -1,0 k € | -121.8% | 4,6 k € | +130.6% | 2,0 k € | -12.5% | 2,3 k € | +317.4% | -1,1 k € | -169.9% | 1,5 k € | |
| Equity | 80,2 k € | +41.1% | 56,8 k € | +1.1% | 56,2 k € | -5.9% | 59,7 k € | +16.8% | 51,2 k € | +5.8% | 48,3 k € | +6.3% | 45,5 k € | +13.2% | 40,2 k € | +25.3% | 32,1 k € | +7.7% | 29,8 k € | -5.0% | 31,3 k € | +80.3% | 17,4 k € | +28.7% | 13,5 k € | +19.9% | 11,3 k € | -8.2% | 12,3 k € | +60.4% | 7,6 k € | +35.5% | 5,6 k € | +68.3% | 3,4 k € | -23.9% | 4,4 k € | |
| Total assets | 621,5 k € | +87.9% | 330,7 k € | +47.1% | 224,8 k € | +11.1% | 202,4 k € | -3.1% | 208,8 k € | +49.9% | 139,3 k € | +14.4% | 121,8 k € | -3.2% | 125,8 k € | +8.8% | 115,6 k € | +8.3% | 106,8 k € | +28.4% | 83,2 k € | +33.5% | 62,3 k € | -5.7% | 66,1 k € | -19.3% | 81,9 k € | +26.8% | 64,6 k € | +16.6% | 55,4 k € | +42.0% | 39,0 k € | +91.7% | 20,4 k € | -1.2% | 20,6 k € | |
| Cash | 176,2 k € | +9.7% | 160,6 k € | +36.8% | 117,4 k € | +84.8% | 63,5 k € | -39.3% | 104,6 k € | +12.6% | 92,9 k € | +37.7% | 67,4 k € | +12.8% | 59,8 k € | +12.1% | 53,3 k € | -15.6% | 63,1 k € | +184.4% | 22,2 k € | +6.3% | 20,9 k € | +37.4% | 15,2 k € | -13.1% | 17,5 k € | +132.9% | 7,5 k € | -34.4% | 11,5 k € | +2174.7% | 503,5 € | -78.9% | 2,4 k € | +9820.5% | 24,0 € | |
| Debts | 541,3 k € | +97.7% | 273,9 k € | +62.4% | 168,6 k € | +18.1% | 142,7 k € | -9.5% | 157,7 k € | +73.3% | 91,0 k € | +19.2% | 76,4 k € | -10.8% | 85,6 k € | +2.5% | 83,6 k € | +8.5% | 77,0 k € | +49.3% | 51,6 k € | +17.6% | 43,9 k € | -15.9% | 52,2 k € | -24.6% | 69,2 k € | +32.8% | 52,1 k € | +11.1% | 46,9 k € | +40.6% | 33,4 k € | +96.2% | 17,0 k € | +4.9% | 16,2 k € | |
Private limited company · Court-Saint-Etienne · incorporated on 12/02/1970
Private limited company profitable but thinly capitalised. Cash position rising (+9.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (80,2 k €) relative to earnings. The abridged model hides revenue.
Clinique des Petits Animaux is a Private limited company incorporated in 1970. Its main activity is: Veterinary activities. Its registered office is in Court-Saint-Etienne.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.